Cellectar biosciences expands iopofosine i 131 collaboration with wisconsin alumni research foundation

Exclusive license agreement to develop and commercialize pediatric cancer treatments exclusive license agreement to develop and commercialize pediatric cancer treatments

CLRB Ratings Summary

CLRB Quant Ranking